Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Exclusive News

 

Penta shortlists investors for first-round bids on PHI

CEE firm Penta Investments' sale of a stake in its hospital business Penta Hospitals International (PHI) has progressed with NDAs signed by a dozen parties and indicative offers expected next month, director Václav Jirků tells HBI.

NMC Health’s Aspen disposal could end with propco takeover

In-administration GCC group NMC Health's attempt to offload UK hospital chain Aspen Healthcare looks to have stalled. An advisor says the opco could be taken over by propco owner NorthWest Healthcare Properties, echoing what happened to the largest operator BMI Healthcare just two years ago.

Synlab and Cerba looking for exits, while Unilabs in ‘no rush’

The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite. 

NMC CEO: Any sale will be a competitive, traditional process

Will the creditors of NMC Healthcare, the GCC's largest for-profit healthcare operator which has been in administration since April 2020, choose a sale of its core UAE business in the next 3-6 months or a longer-term, creditor-led restructuring? We talk exclusively to NMC CEO Michael Davis and UAE sources. A 'fire sale' of parts of its core UAE business now seems entirely off the table.

Revealed: Babylon’s real revenue in 2020

Recently filed accounts for UK telehealth unicorn Babylon show the group made £6m sales with almost £100m losses in 2019. However, a well-placed source gives HBI a more accurate picture of the holding company's accounts, filed privately in Jersey.

Orpea to build universities across world after academy acquisition

Pan-European nursing home group Orpea has acquired a training academy in Austria, HBI can reveal. It signals a new wave for the group, which tells HBI that it wants to be known in five to ten years as a school, alongside its care and property arms. It will use the licence to build a university campus, doubling the number of people trained locally, and then duplicate this model across all its markets.

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.

Find Us